Published in Hepatitis Weekly, December 7th, 1998
Researcher D.E. Zembower and colleagues evaluated the activity of robustaflavone in the presence of more established therapies for hepatitis B ("Robustaflavone, A Potential Non-Nucleoside Anti-Hepatitis B Agent," Antiviral Research, August 1998;39(2):81-88).
Robustaflavone, a naturally occurring biflavanoid isolated from Rhus succedanea, was found to be a potent inhibitor of hepatitis B virus (HBV) replication in 2.2.15 cells, with an effective concentration (EC50 ) of 0.25 microM, and a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.